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Introduction: Coronavirus disease 2019 (COVID-19) was first described in China, in patients with flu-like 
symptoms in December 20191. This family of viruses is known for its cardiotropism2. Arrhythmia is pos-
sible clinical manifestation in COVID-19 patients and several cases of COVID-19 myocarditis have been 
reported, some as a cause of death3.
Case report: We present a case of a 37-years old, previously healthy, female patient who was admitted 
to COVID-19 Intensive care unit (ICU) at University Hospital Centre Zagreb after out of hospital cardi-
ac arrest and successful resuscitation. She manifested episodes of chest pain and palpitations during 
two months prior to cardiac arrest. Initial laboratory findings showed elevated levels of high-sensitive 
troponin I and NT-proBNP, significant hypokalemia and normal values of C-reactive protein. Additional 
urgent work-up (pulmonary CT angiography and brain CT scan) showed no significant pathology and 
Sars-Cov-2 PCR RNA test came positive, without 
respiratory involvement. Due to ECG changes and 
ultrasound finding of reduced left ventricular 
ejection fraction (LVEF 25-30%) with anteroseptal 
and apical akinesia and inferior hypokinesia, ur-
gent coronary angiography was performed, there 
were no signs of coronary artery disease, and the 
suspected diagnosis was Takotsubo cardiomyo-
pathy or myocarditis. Soon after admission heart 
failure therapy was introduced, and follow-up 
echocardiography showed improvement in LVEF 
(40-45%). Patient was given no specific antiviral 
treatment nor corticosteroid therapy. Additional 
work-up regarding serology for cardiotropic vi-
ruses came negative, and IgG antibodies for Cov-
id-19 showed borderline result. Cardiac magnetic 
resonance imaging (MRI) performed 18 days after 
initial event described recovered left ventricular 
ejection fraction (LVEF 53%), with mild hypoki-
nesia, oedema and mid-wall late gadolinium en-
hancement in apical 2/3 of anterior, anteroseptal 
and anterolateral wall, with pattern characteris-
tic for myocarditis (Figure 1)4. At follow-up, one 
month after discharge, patient is completely 
recovered, without signs of heart failure or ar-
rhythmias, with preserved LVEF and normal NT-
proNBP levels.
Conclusion: This case once again highlights cardiac complications of SARS-CoV-2 infection, without 
respiratory involvement. Also, it shows good prognosis without specific antiviral treatment, emphasizing 
importance of early introduction of heart failure therapy.
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Figure 1. Cardiac magnetic resonance imaging (MRI) findings consistent with typical 
characteristics of myocarditis; A) MRI (2-chamber view) shows a high intensity area of 
the left ventricular wall on T2-weighted short-tau inversion recovery STIR, consistent 
with myocardial oedema in apical 2/3 of the anterior, anteroseptal and anterolateral 
wall (arrow); B) MRI native T1 mapping (SAX; short axis view) shows significantly 
increased native myocardial T1 values - mean value 1267 ms in comparison with 
normal myocardium mean value of 1025 ms in the same area (arrow), where native 
myocardial T2 values were also increased - mean value 70 ms in comparison with nor-
mal myocardium mean value of 53 ms (image not shown); C) MRI (SAX view) shows 
post-contrast enhancement on LGE of mid-wall distribution in the same area (arrow). 
LV- left ventricle, RV- right ventricle.
